FLGT

24.1202.66%
HG

Hanlin Gao

Chief Scientific Officer & Lab Director

Dr. Hanlin Gao, also known as Harry, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G., has been the Chief Scientific Officer since January 2016 and Lab Director at Fulgent Genetics, Inc. since February 2012. Dr. Gao is the Founder of genetic testing business of Fulgent. He serves as a Team Leader for laboratory inspections by CAP. He has a wealth of experience and achievements. He has become an Industry-Leading Expert in the use of new DNA sequencing technologies for clinical diagnostics as well as basic and translational research. His prior experience includes service as Lab Director of both the DNA Sequencing Core Laboratory and Clinical Molecular Diagnostics Laboratory at City of Hope from 2004 to 2013. Dr. Gao completed his Clinical Molecular Genetics Training Fellowship and Post-Doctoral Fellowship at Harvard Medical School in 2004 prior to joining City of Hope. Dr. Gao received a M.S. in Immunology and an M.D. from Peking University and Inner Mongolia University for Nationalities in China in 1993 and 1990, respectively, as well as a Ph.D. in Microbiology, Immunology and Medical Genetics from The Ohio State University in 2001. Dr. Gao is Board Certified in Clinical Molecular Genetics by the American Board of Medical Genetics, is a Fellow of the American College of Medical Genetics and Genomics and serves as a team leader for laboratory inspections by the College of American Pathologists.

Positions